CLINICAL_TRIALS
ClinicalTrials.gov record update
Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) (ABROGATE)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02108860
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:20.965023+00:00
- Published At
- 2024-07-29T00:00:00+00:00
- Record Updated At
- 2024-07-29
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Granulomatosis With Polyangiitis (Wegener\u0027s)", "Granulomatosis With Polyangiitis", "Wegener\u0027s Granulomatosis", "ANCA-Associated Vasculitis"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-07-29"- protocolSection.identificationModule.nctId
"NCT02108860"- protocolSection.identificationModule.officialTitle
"Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener\u0027s) (ABROGATE)"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.